Trupanion, Inc. (TRUP)

Trupanion's stock has experienced fluctuations over the past six months. As of October 17, 2025, the share price was $42.90, a decline of 20.42% from October 21, 2024. Over the last 12 months, the stock's price decreased by 18.30%, with a year-to-date return of -9.13%, but in the past month, the stock has shown a positive trend, increasing by 2.00%. Key corporate events include a leadership transition in August 2024, an Investor Day on September 17, 2025, and the announcement of its third-quarter 2025 earnings release and conference call for November 6, 2025. In its Q1 2025 results, Trupanion reported a 12% year-over-year revenue surge and a narrowing of net losses.

The global pet insurance market is experiencing robust growth driven by increasing pet ownership and the humanization of pets. The market demonstrates consistent expansion, with projections of reaching $6226.7 million in 2025 and exhibiting a Compound Annual Growth Rate (CAGR) of 13.5% from 2025 to 2033. The growth appears to be a continuous trend rather than being tied to particular seasons.

Trupanion, Inc. is a provider of medical insurance for cats and dogs, operating on a subscription basis within the Financials sector. Its core offering is its branded medical insurance product, known for comprehensive coverage and direct payment to veterinarians. The company has expanded its product portfolio to include other brands such as Furkin, PHI Direct, Smart Paws and Pet Expert.

Trupanion, Inc. offers its pet insurance services across the United States, Canada, Continental Europe, Australia, and Puerto Rico.

Trupanion has maintained a positive brand reputation, particularly concerning its workplace culture. In July 2025, the company was honored with the Puget Sound Business Journal's Excellence in Wellbeing Award. Additionally, Trupanion announced its 2025 truFame Winners, highlighting pets that will become the new faces of the brand. Trupanion has been recognized for its pet-friendly policies and as a "Best Place to Work."

Trupanion, Inc. is largely owned by institutional investors, who held 93.74% of the company's shares as of May 2025. Major institutional shareholders include BlackRock, Inc., Capital World Investors, Aflac Inc, Vanguard Group Inc, SMCWX - SMALLCAP WORLD FUND INC Class A, Wellington Management Group Llp, IJR - iShares Core S&P Small-Cap ETF, AGTHX - GROWTH FUND OF AMERICA Class A, Bank Of America Corp /de/, and Polar Capital Holdings Plc. Insiders collectively hold 3.84% of the shares, with Dan Levitan owning 6.66 million shares, representing 15.56% of the company.